Bank of New York Mellon’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $875K | Sell |
175,782
-7,160
| -4% | -$35.7K | ﹤0.01% | 3189 |
|
|
2025
Q1 | $807K | Sell |
182,942
-9,670
| -5% | -$42.6K | ﹤0.01% | 3164 |
|
|
2024
Q4 | $896K | Buy |
192,612
+17,633
| +10% | +$82K | ﹤0.01% | 3203 |
|
|
2024
Q3 | $1.21M | Buy |
174,979
+8,002
| +5% | +$55.5K | ﹤0.01% | 3020 |
|
|
2024
Q2 | $1.3M | Sell |
166,977
-5,597
| -3% | -$43.7K | ﹤0.01% | 3041 |
|
|
2024
Q1 | $1.23M | Sell |
172,574
-33,069
| -16% | -$235K | ﹤0.01% | 3034 |
|
|
2023
Q4 | $1.38M | Buy |
205,643
+16,083
| +8% | +$108K | ﹤0.01% | 3018 |
|
|
2023
Q3 | $1.07M | Buy |
189,560
+13,235
| +8% | +$74.5K | ﹤0.01% | 3107 |
|
|
2023
Q2 | $973K | Buy |
176,325
+3,268
| +2% | +$18K | ﹤0.01% | 3202 |
|
|
2023
Q1 | $1.08M | Sell |
173,057
-15,680
| -8% | -$98K | ﹤0.01% | 3098 |
|
|
2022
Q4 | $880K | Buy |
188,737
+143,145
| +314% | +$667K | ﹤0.01% | 3254 |
|
|
2022
Q3 | $213K | Sell |
45,592
-2,480
| -5% | -$11.6K | ﹤0.01% | 3989 |
|
|
2022
Q2 | $284K | Buy |
48,072
+8,797
| +22% | +$52K | ﹤0.01% | 3913 |
|
|
2022
Q1 | $759K | Buy |
39,275
+412
| +1% | +$7.96K | ﹤0.01% | 3472 |
|
|
2021
Q4 | $1.27M | Sell |
38,863
-733
| -2% | -$24K | ﹤0.01% | 3250 |
|
|
2021
Q3 | $1.62M | Buy |
39,596
+4,999
| +14% | +$205K | ﹤0.01% | 3114 |
|
|
2021
Q2 | $1.25M | Buy |
34,597
+10,124
| +41% | +$365K | ﹤0.01% | 3274 |
|
|
2021
Q1 | $955K | Sell |
24,473
-5,157
| -17% | -$201K | ﹤0.01% | 3353 |
|
|
2020
Q4 | $1.2M | Buy |
+29,630
| New | +$1.2M | ﹤0.01% | 3162 |
|